CCO Oncology Podcast

189 Episodes

1. Targeting FGFR in Urothelial Cancer and Beyond

   Published: 3/23/2021
2. Expert Answers to HCP Questions on Pancreatic Cancer Treatment

   Published: 3/22/2021
3. Expert Answers to HCP Questions on CAR T-Cell Therapies in Lymphoma

   Published: 3/18/2021
4. Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

   Published: 3/17/2021
5. Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities

   Published: 3/12/2021
6. Expert Insights on Highlights From ASH 2020 on Multiple Myeloma

   Published: 3/12/2021
7. Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias

   Published: 2/26/2021
8. Expert Insight on Key Data From WCLC 2020 in Early-Stage Lung Cancer

   Published: 2/24/2021
9. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina

   Published: 2/22/2021
10. Expert Insights on Key Data From ASH 2020 on Nonmalignant Hematologic Disorders

    Published: 2/10/2021
11. Expert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms

    Published: 2/5/2021
12. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy

    Published: 2/4/2021
13. Expert Answers to Questions on Contemporary Management of Hemophilia A

    Published: 2/4/2021
14. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States

    Published: 2/1/2021
15. An Expert Overview of Immunotherapy for Advanced HCC

    Published: 1/19/2021
16. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain

    Published: 1/8/2021
17. Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance

    Published: 12/28/2020
18. Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ

    Published: 12/24/2020
19. Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC

    Published: 12/21/2020
20. Immunotherapy for Advanced HCC: Experts Answer Clinician Questions

    Published: 12/17/2020